Research.Patient.info
Gastroesophageal Adenocarcinoma research hub
2 indexed studies · 2 currently recruiting
- recruitingPHASE2
Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients
This study looks at a new combination of medicines (Zanidatamab, Pembrolizumab, and chemotherapy) for advanced stomach or food pipe cancer that has spread. It focuses on patients whose cancer has specific markers (HER2 and PD-L1 positive) and haven't had previous treatment for advanced disease.
Germany - recruitingPHASE1
A Phase 1/1b Study of IAM1363 in HER2 Cancers
This study is testing a new medicine called IAM1363 for advanced cancers with a specific change called HER2. It aims to find a safe and effective dose, including for breast, lung, and stomach cancers that have spread to the brain.
United States · France · Ireland